bacteri
enter
infect
result
diarrhea
dysenteri
enter
fever
constitut
huge
public
health
problem
billion
episod
diseas
annual
develop
develop
countri
studi
deadli
agent
hemorrhag
diarrhea
hemolyt
urem
syndrom
escherichia
coli
investig
extens
comput
approach
aim
identifi
novel
broadspectrum
antibiot
target
systemat
silico
workflow
consist
compar
genom
metabol
pathway
analysi
addit
drug
priorit
paramet
use
identifi
novel
drug
target
essenti
pathogen
surviv
absent
human
host
compar
genom
analysi
kyoto
encyclopedia
gene
genom
annot
metabol
pathway
identifi
put
target
protein
e
coli
show
similar
human
protein
bioinformat
approach
includ
predict
subcellular
local
calcul
molecular
weight
webbas
investig
structur
characterist
greatli
aid
filter
potenti
drug
target
ultim
nonhomolog
essenti
protein
e
coli
priorit
prove
elig
becom
novel
broadspectrum
antibiot
target
dna
polymeras
iii
alpha
dnae
toprank
among
target
moreov
druggabl
identifi
drug
target
evalu
drugbank
databas
addit
structur
dnae
model
explor
silico
dock
ligand
potenti
druggabl
final
confirm
compound
ncoeleneterazin
n
suitabl
ligand
dnae
henc
propos
potenti
inhibitor
target
protein
result
studi
could
facilit
discoveri
releas
new
effect
drug
e
coli
deadli
human
bacteri
pathogen
enteropathogen
escherichia
coli
enterohemorrhag
e
coli
ehec
infect
human
major
sourc
morbid
mortal
develop
develop
countri
among
variou
pathogen
e
coli
strain
caus
intestin
extraintestin
diseas
human
devast
shiga
toxin
produc
ehec
strain
caus
diarrhea
hemorrhag
coliti
also
lifethreaten
hemolyt
urem
syndrom
encephalopathi
serotyp
shiga
toxinproduc
e
coli
associ
human
infect
common
serotyp
e
coli
sever
deadli
outbreak
e
coli
report
canada
unit
state
great
britain
japan
submit
manuscript
wwwdovepresscom
mondal
et
al
howev
massiv
outbreak
sakai
citi
japan
great
concern
number
death
infect
report
genom
ehec
sakai
strain
sequenc
sequenc
analysi
reveal
strain
contain
prophag
six
prophagelik
element
two
plasmid
posakl
know
mechan
underli
pathogen
bacterium
substanti
number
virulencerel
gene
function
associ
variou
stage
infect
identifi
howev
lack
detail
function
annot
often
limit
possibl
use
target
design
new
drug
pathogen
treatment
e
coli
mostli
reli
convent
antibiot
therapi
although
studi
highlight
evid
improv
cours
diseas
antibiot
treatment
patient
e
coli
infect
increas
risk
hemolyticurem
syndrom
moreov
increas
antibiot
resist
report
e
coli
last
year
also
alarm
accumul
result
strongli
suggest
urgent
continu
need
find
new
drug
vaccin
candid
tackl
deadli
pathogen
drug
target
identif
first
step
drug
discoveri
process
howev
tradit
drug
discoveri
method
timeconsum
expens
often
yield
drug
target
contrast
advanc
complet
genom
sequenc
bioinformat
cheminformat
repres
attract
altern
approach
identifi
drug
target
worthi
experiment
followup
avail
pathogen
hostgenom
sequenc
becom
easier
identifi
drug
target
genom
level
given
pathogen
recent
year
comput
method
use
wide
identif
potenti
drug
vaccin
target
differ
pathogen
microorgan
subtract
compar
genom
approach
combin
metabol
pathway
analysi
found
effici
way
identifi
proteinset
essenti
pathogen
surviv
absent
host
subtract
host
genom
essenti
gene
pathogen
help
search
nonhuman
homolog
target
ensur
interact
drug
human
target
hand
compar
genom
method
emphas
select
conserv
protein
amongst
sever
speci
favor
target
use
advanc
bioinformat
tool
integr
genom
proteom
metabolom
may
ensur
discoveri
potenti
drug
target
infecti
diseas
target
identifi
silico
virtual
screen
differ
chemic
databas
could
provid
unpreced
opportun
select
design
best
possibl
inhibitor
studi
took
indepth
silico
approach
identifi
novel
therapeut
target
e
coli
sakai
strain
combin
analysi
metabolom
genom
data
instead
analysi
whole
genom
particularli
consid
key
essenti
surviv
protein
pathogen
nonhomolog
host
elucid
good
number
novel
target
e
coli
design
effect
drug
broadspectrum
pathogen
bacteria
moreov
provid
model
structur
dna
polymeras
iii
alpha
dnae
select
best
possibl
target
inhibit
design
potenti
drug
best
knowledg
first
silico
identif
drug
target
e
coli
pathway
analysi
protein
retriev
figur
show
strategi
identif
suitabl
drug
target
predict
inhibitor
use
kyoto
encyclopedia
gene
genom
kegg
databas
search
metabol
pathway
human
genom
e
coli
sakai
strain
identif
number
pathway
organ
list
manual
comparison
made
pathway
appear
human
genom
present
pathogen
accord
kegg
databas
annot
select
uniqu
e
coli
remain
pathway
list
common
amino
acid
sequenc
protein
common
uniqu
pathway
obtain
uniprotkb
identif
essenti
protein
nonhomolog
protein
human
databas
essenti
gene
deg
use
identifi
essenti
protein
involv
hostpathogen
pathway
deg
databas
retriev
http
wwwtubic
tjueducndeg
bioedit
sequenc
align
editor
version
use
protein
basic
local
align
search
tool
blastp
search
screen
elimin
probabl
essenti
protein
organ
set
evalu
cut
sequenc
ident
bit
score
other
default
human
protein
sequenc
retriev
refseq
databas
ftp
site
ftp
ftpncbinlmnihgovgenomesh
sapiensprotein
essenti
protein
subject
blastp
search
human
protein
bioedit
nonhit
protein
evalu
cut
drug
target
identif
subtract
genom
analysi
approach
select
nonhomolog
protein
avoid
function
similar
host
proteom
subcellular
local
predict
essenti
nonhuman
protein
done
psortb
version
predict
three
type
local
cytoplasm
membran
extracellular
protein
gramneg
bacteria
potenti
drug
target
evalu
sever
molecular
structur
criteria
mondal
et
al
ligand
bind
site
human
protein
structur
web
server
smapw
cut
valu
sequenc
ident
moreov
druggabl
anoth
import
priorit
criterion
therapeut
target
defin
likelihood
abl
modul
activ
therapeut
target
protein
smallmolecul
drug
druggabl
identifi
drug
target
measur
mine
drugbank
content
blastp
default
paramet
perform
list
target
compound
found
within
drugbank
align
potenti
drug
target
e
coli
align
evalu
less
signific
remov
describ
previous
select
criteria
filter
blast
result
identifi
drug
target
bacteri
genom
identif
novel
target
search
common
protein
identifi
novel
target
among
potenti
target
databas
drugbank
supertarget
therapeut
target
databas
search
similar
cytoplasm
protein
paramet
set
evalu
sequenc
ident
bit
score
nonhit
protein
threshold
valu
select
novel
drug
target
search
common
protein
amongst
pathogen
bacteria
protein
sequenc
differ
strain
pathogen
bacteria
retriev
patric
databas
novel
target
subject
blastp
proteom
evalu
cut
sequenc
ident
bit
score
bioedit
softwar
protein
found
common
least
pathogen
strain
proteom
list
broadspectrum
target
differ
bacteri
speci
use
refer
exact
protein
data
bank
pdb
structur
avail
dnae
pdb
subject
blast
search
pdb
structur
use
evalu
cut
templat
homolog
model
chosen
consid
xray
diffract
resolut
highest
sequenc
similar
homolog
model
done
server
model
structur
assess
swissmodel
structur
assess
tool
anolea
atom
nonloc
environ
assess
assess
pack
qualiti
model
procheck
suit
program
check
stereochem
qualiti
protein
structur
energi
minim
carri
default
paramet
implement
swiss
pdb
viewer
version
activ
site
model
structur
determin
castp
server
virtual
screen
drug
likeli
toxic
analysi
visual
analysi
comparison
activ
site
interact
ligand
ligand
molecul
e
coli
dnae
subunit
extract
bindingdb
databas
dock
subject
receptor
virtual
screen
done
total
molecul
experiment
approv
molecul
deposit
drugbank
base
select
activ
site
dnae
virtual
screen
perform
linux
ubuntu
base
cluster
core
system
top
molecul
select
base
lowest
bind
energi
dock
sever
time
select
molecul
analyz
lipinski
rule
five
ligand
interact
analysi
visual
done
help
pymol
discoveri
studio
accelri
san
diego
ca
usa
absorpt
distribut
metabol
excret
toxic
admet
predict
carri
preadmet
server
preadmet
predict
mutagen
carcinogen
compound
help
avoid
toxic
compound
oral
bioavail
predict
program
mobyl
rpb
server
report
first
comput
compar
subtract
genom
analysi
differ
metabol
pathway
e
coli
identif
potenti
drug
target
systemat
workflow
defin
involv
sever
bioinformat
tool
databas
drug
target
priorit
paramet
figur
goal
obtain
inform
protein
involv
variou
metabol
pathway
e
coli
absent
host
therefor
avoid
potenti
side
effect
search
kegg
databas
pathogen
metabol
pathway
total
differ
pathway
appear
order
identifi
drug
target
involv
pathogenspecif
metabol
pathway
compar
analysi
metabol
pathway
host
pathogen
perform
detail
pathway
analys
reveal
total
pathway
present
pathogen
term
pathogenspecif
pathway
remain
pathogen
pathway
defin
common
hostpathogen
pathway
list
tabl
pentos
phosphat
pathway
sulfur
metabol
pentos
glucuron
interconvers
aminoacyltrna
biosynthesi
fructos
mannos
metabol
biosynthesi
unsatur
fatti
acid
galactos
metabol
abc
transport
ascorb
aldar
metabol
ribosom
fatti
acid
biosynthesi
rna
degrad
fatti
acid
metabol
rna
polymeras
ubiquinon
terpenoidquinon
biosynthesi
dna
replic
oxid
phosphoryl
protein
export
purin
metabol
base
excis
repair
pyrimidin
metabol
nucleotid
excis
repair
alanin
aspart
glutam
metabol
mismatch
repair
glycin
serin
threonin
metabol
homolog
recombin
cystein
methionin
metabol
sulfur
relay
system
valin
leucin
isoleucin
degrad
glycerolipid
metabol
valin
leucin
isoleucin
biosynthesi
inositol
phosphat
metabol
lysin
biosynthesi
glycerophospholipid
metabol
lysin
degrad
arachidon
acid
metabol
arginin
prolin
metabol
alphalinolen
acid
metabol
histidin
metabol
sphingolipid
metabol
tyrosin
metabol
pyruv
metabol
phenylalanin
metabol
glyoxyl
dicarboxyl
metabol
tryptophan
metabol
propano
metabol
phenylalanin
tyrosin
tryptophan
biosynthesi
butano
metabol
betaalanin
metabol
one
carbon
pool
folat
taurin
hypotaurin
metabol
thiamin
metabol
selenocompound
metabol
riboflavin
metabol
cyanoamino
acid
metabol
vitamin
metabol
dglutamin
dglutam
metabol
nicotin
nicotinamid
metabol
glutathion
metabol
pantothen
coa
biosynthesi
starch
sucros
metabol
biotin
metabol
glycan
degrad
lipoic
acid
metabol
amino
sugar
nucleotid
sugar
metabol
folat
biosynthesi
pathogenspecif
pathway
geraniol
degrad
aminobenzo
degrad
chlorocyclohexan
chlorobenzen
degrad
nitrotoluen
degrad
benzoat
degrad
ethylbenzen
degrad
bisphenol
degrad
dibas
acid
metabol
fluorobenzo
degrad
methan
metabol
novobiocin
biosynthesi
limonen
pinen
degrad
phosphon
phosphin
metabol
streptomycin
biosynthesi
biosynthesi
siderophor
group
nonribosom
peptid
polyketid
sugar
unit
biosynthesi
biosynthesi
secondari
metabolit
lipopolysaccharid
biosynthesi
microbi
metabol
divers
environ
peptidoglycan
biosynthesi
twocompon
system
dioxin
degrad
bacteri
chemotaxi
xylen
degrad
flagellar
assembl
toluen
degrad
phosphotransferas
system
polycycl
aromat
hydrocarbon
degrad
bacteri
secret
system
chloroalkan
chloroalken
degrad
pathogen
escherichia
coli
infect
naphthalen
degrad
effect
drug
target
protein
crucial
surviv
pathogen
host
bodi
nonhomolog
human
protein
criterion
prerequisit
avoid
cross
bind
drug
human
protein
drug
side
effect
probabl
uniqu
pathway
specif
pathogen
absent
host
protein
pathway
also
consid
uniqu
pathogen
might
serv
potenti
drug
vaccin
target
moreov
sever
uniqu
protein
known
present
common
pathway
identifi
analysi
e
coli
data
shown
sever
previou
studi
bacteria
addit
also
identifi
singl
uniqu
protein
also
take
part
multipl
pathway
protein
involv
one
pathway
could
effect
drug
target
addit
nonhomolog
protein
nevertheless
uniqu
nonhuman
involv
metabol
pathway
sole
criteria
select
favor
drug
target
possibl
bacteri
protein
show
similar
host
protein
might
involv
multipl
metabol
pathway
disrupt
might
therapeut
benefit
reason
may
includ
presenc
paralog
isoenzym
importantli
nonessenti
pathogen
surviv
essenti
protein
nonhomolog
natur
therefor
pathogen
protein
fulfil
criteria
uniqu
essenti
time
repres
attract
drug
target
base
criteria
discuss
identifi
probabl
essenti
protein
hostpathogen
common
pathway
pathogen
uniqu
pathway
supplementari
materi
protein
show
good
similar
experiment
proven
essenti
protein
record
deg
databas
blastp
search
human
proteom
narrow
target
proteom
protein
common
pathway
uniqu
pathway
respect
result
protein
essenti
pathogen
surviv
nonhomolog
host
supplementari
materi
local
protein
cell
import
factor
identif
suitabl
effect
drug
target
membran
local
protein
difficult
purifi
assay
therefor
cytoplasm
protein
favor
drug
target
major
factor
access
valu
target
protein
prefer
low
mw
kda
whether
potenti
drug
transmembran
protein
avail
structur
inform
base
essenti
featur
identifi
nonhomolog
essenti
protein
e
coli
character
protein
mw
less
kda
indic
possibl
experiment
studi
protein
drug
develop
common
pathway
protein
found
cytoplasm
protein
membran
local
protein
unknown
local
pathogen
uniqu
pathway
eight
protein
found
cytoplasm
membran
local
unknown
local
respect
supplementari
materi
base
result
cytoplasm
protein
common
pathway
uniqu
pathway
respect
consid
analysi
identifi
suitabl
drug
target
figur
drugbank
uniqu
bioinformat
cheminformat
resourc
combin
detail
drug
data
comprehens
inform
drug
target
util
drugbank
databas
druggabl
nonhomolog
essenti
protein
e
coli
measur
sequenc
similar
target
smallmolecul
drug
blastp
search
perform
align
nonhomolog
essenti
protein
list
drugtarget
protein
drugbank
total
protein
e
coli
show
high
similar
bind
partner
us
food
drug
administr
fda
approv
drug
experiment
smallmolecul
compound
nutraceut
compound
support
potenti
compar
genom
drug
discoveri
among
protein
protein
common
uniqu
pathway
respect
supplementari
materi
comparison
drugtarget
protein
addit
list
approv
drug
druglik
compound
identifi
bind
protein
similar
sequenc
e
coli
reason
care
filter
drug
target
identif
subtract
genom
analysi
approach
set
could
reveal
number
potenti
compound
prime
optim
derivat
use
tradit
medicin
chemistri
although
protein
sequenc
similar
guarante
ident
structur
bind
pocket
search
presenc
structur
nonhost
essenti
protein
e
coli
inform
could
greatli
facilit
structurebas
drug
design
includ
homolog
model
dock
virtual
screen
pharmacophorebas
screen
pdb
modbas
use
sourc
structur
inform
nonhost
essenti
protein
ten
protein
identifi
experiment
determin
structur
pdb
found
model
modbas
supplementari
materi
protein
show
signific
similar
databas
discard
remain
protein
sequenc
taken
novel
target
fortyfour
protein
pathogen
uniqu
pathway
protein
common
pathway
total
protein
defin
novel
protein
supplementari
materi
metabol
pathway
analysi
indic
protein
involv
biolog
process
uniqu
pathogen
biolog
process
common
host
pathogen
moreov
biolog
process
classifi
class
amino
acid
metabol
carbohydr
metabol
energi
metabol
glycan
biosynthesi
metabol
lipid
metabol
metabol
cofactor
vitamin
metabol
amino
acid
nucleotid
metabol
genet
inform
process
environment
inform
process
cellular
process
other
supplementari
materi
figur
show
percentag
distribut
novel
drug
target
involv
differ
biolog
process
studi
reveal
protein
uniqu
involv
pathogenspecif
uniqu
pathway
lipopolysaccharid
lp
biosynthesi
peptidoglycan
biosynthesi
methan
metabol
dibas
acid
metabol
nitrogen
metabol
phosphon
phosphin
metabol
bacteri
secret
system
phosphotransferas
system
pt
flagellar
assembl
twocompon
system
biosynthesi
siderophor
group
nonribosom
peptid
bacteri
chemotaxi
three
enzym
lp
core
biosynthesi
three
enzym
lipid
pathway
found
uniqu
present
lp
biosynthesi
pathway
kegg
pathway
lp
enterobacteriacea
core
oligosaccharid
respons
mani
biolog
properti
antigen
opolysaccharid
hand
enzym
lipid
pathway
requir
bacteri
growth
could
excel
target
develop
new
antibiot
moreov
murf
ec
enzym
present
peptidoglycan
biosynthesi
kegg
pathway
gramposit
bacteria
cell
wall
compos
peptidoglycan
macromolecul
mani
surfac
protein
gramposit
bacteria
thought
import
surviv
within
infect
host
advanc
applic
bioinformat
chemistri
submit
manuscript
wwwdovepresscom
methan
metabol
kegg
pathway
acka
ec
found
uniqu
present
methanotroph
involv
global
methan
cycl
consum
methan
sole
sourc
carbon
energi
grow
wherea
methanogen
obtain
energi
growth
convert
limit
number
substrat
methan
protein
ilvh
acetolact
synthas
iii
small
subunit
uniqu
protein
present
dibas
acid
metabol
kegg
pathway
provid
altern
sourc
carbon
energi
uniqu
presenc
four
protein
nitrogen
metabol
keeg
pathway
nitrogen
cycl
differ
reduct
oxid
reaction
util
prokaryot
energi
conserv
case
oxygen
depriv
growth
condit
e
coli
anaerob
respir
nitrat
prefer
electron
acceptor
put
resist
protein
identifi
uniqu
protein
present
phosphon
phosphin
metabol
kegg
pathway
natur
product
contain
carbonphosphor
bond
socal
cp
compound
found
mani
organ
protist
bacteria
mostli
actinobacteria
biosynthet
capac
moreov
secb
proteinexport
protein
secb
etpn
type
prepilinlik
protein
leader
peptideprocess
enzym
part
bacteri
secret
system
kegg
pathway
found
uniqu
mani
protein
implic
efflux
differ
toxin
drug
virul
biogenesi
differ
organel
pili
flagella
secret
secb
involv
effici
export
protein
across
cytoplasm
membran
e
coli
pt
kegg
pathway
protein
found
uniqu
present
known
pt
involv
transport
carbohydr
bacteria
play
major
role
phosphoryl
uptak
carbohydr
control
metabol
flagellar
flij
protein
part
flagellar
assembl
kegg
pathway
well
put
gener
chaperon
cytoplasm
protein
identifi
uniqu
pathogen
bacteri
flagellum
extend
cytoplasm
cell
exterior
serv
motor
organel
protein
exportassembl
apparatu
total
protein
identifi
uniqu
pathogenspecif
pathway
twocompon
system
kegg
pathway
bacteri
twocompon
system
requir
adapt
extern
stimuli
affect
chang
cellular
physiolog
singl
protein
identifi
involv
biosynthesi
siderophor
group
nonribosom
peptid
pathway
polyketid
synthas
nonribosom
polypeptid
synthetas
known
respons
biosynthesi
sever
siderophor
enterobactin
e
coli
two
protein
detect
case
bacteri
chemotaxi
chemotaxi
bacteria
sens
chemic
gradient
environ
move
toward
favor
condit
pathway
arguabl
best
character
case
e
coli
novel
target
common
hostpathogen
pathway
also
identifi
protein
hostpathogen
common
metabol
pathway
novel
target
pathway
group
metabol
amino
acid
carbohydr
energi
lipid
amino
acid
nucleotid
cofactor
vitamin
genet
inform
process
environment
inform
process
cellular
process
other
supplementari
materi
common
protein
among
sever
speci
would
well
broadspectrum
antibiot
target
use
speci
refer
protein
common
least
differ
speci
list
broadspectrum
target
supplementari
materi
fortyfour
protein
identifi
broadspectrum
target
supplementari
materi
addit
broadspectrum
protein
involv
multipl
pathway
would
better
target
inhibit
activ
hamper
one
system
pathogen
dnae
subunit
acka
involv
maximum
number
pathway
acka
catalyz
revers
reaction
format
acetyl
phosphat
acet
atp
wherea
dnae
particip
critic
pathway
pathogen
like
purin
metabol
pyrimidin
metabol
dna
replic
mismatch
repair
homolog
recombin
resolv
xray
crystallographi
structur
dnae
e
coli
sakai
strand
acka
e
coli
sakai
strand
intend
homolog
model
howev
dnae
subunit
uniprot
id
prefer
acka
uniprot
id
base
suitabl
homolog
model
dock
studi
blast
search
pdb
structur
threshold
evalu
dnae
subunit
show
sequenc
ident
e
coli
replic
dnae
subunit
pdb
id
wherea
acka
salmonella
enterica
subspeci
enterica
serovar
typhimurium
acka
pdb
id
data
shown
furthermor
interdomain
motion
ligand
bind
well
ligand
bind
pocket
locat
advanc
applic
bioinformat
chemistri
drug
target
identif
subtract
genom
analysi
approach
dimer
interfac
formii
acka
report
hard
address
silico
dock
softwar
case
dnae
subunit
literatur
search
help
us
identifi
pocket
ligand
bind
well
import
conserv
residu
within
pocket
import
catalyt
activ
moreov
conduct
blast
search
dnae
uniprot
id
evalu
cut
uniprotkb
select
organ
whose
protein
show
least
sequenc
ident
dnae
organ
search
patric
databas
check
host
pathogen
human
host
consid
predict
pathogen
involv
diseas
accord
patric
databas
found
organ
pathogen
except
lelliottia
kluyvera
hafnia
ewingella
cedecea
yokenella
howev
literatur
search
help
us
conclud
kluyvera
yokenella
ewingella
hafnia
cedecea
also
involv
diseas
find
suffici
inform
lelliottia
thu
clearli
demonstr
e
coli
dnae
share
sequenc
similar
nonpatholog
bacteri
dnae
therefor
due
advantag
dnae
select
homolog
model
subsequ
structurebas
drug
design
dna
polymeras
iii
holoenzym
ten
differ
peptid
arrang
asymmetr
dimer
contain
exonucleas
activ
alpha
subunit
core
enzym
mainli
function
polymeras
activ
best
hit
similar
search
identifi
crystal
structur
catalyt
alpha
subunit
e
coli
replic
dnae
dna
polymeras
iii
pdb
id
show
sequenc
similar
target
sequenc
use
templat
homolog
model
model
structur
shown
figur
advanc
toward
way
silico
drug
design
protein
model
depend
larg
qualiti
model
inspect
psiphi
ramachandran
plot
analysi
show
model
built
residu
favor
region
residu
addit
allow
region
residu
gener
allow
region
good
qualiti
model
would
expect
favor
region
figur
structur
also
verifi
anolea
yaxi
plot
repres
energi
amino
acid
protein
chain
show
maximum
residu
favor
energi
environ
figur
result
structur
model
consid
good
qualiti
model
analysi
obtain
better
refin
model
energi
minim
done
use
swiss
pdb
viewer
minim
energi
use
forcefield
energi
overal
structur
minim
kjmol
kjmol
respect
activ
site
region
surfac
enzym
specif
substrat
ligand
set
substrat
ligand
bind
properti
activ
site
determin
sequenc
amino
acid
arrang
polypeptid
chain
enzym
identif
activ
site
e
coli
sakai
strain
dnae
done
castp
server
server
calcul
surfac
area
volum
pocket
given
structur
addit
also
show
activ
site
residu
activ
site
residu
volum
shown
figur
literatur
search
help
us
identifi
import
residu
within
pocket
structur
catalyt
alpha
subunit
e
coli
known
three
conserv
residu
aspart
asp
asp
asp
model
ensur
align
refer
structur
data
shown
four
conserv
virtual
screen
drug
likeli
toxic
analysi
dnae
inform
molecul
bind
interact
taken
refer
predict
conveni
inhibitor
dnae
e
coli
sakai
strand
molecul
drugbank
figur
top
hit
drugbank
show
lower
bind
energi
dock
five
time
filter
lipinski
rule
five
reduc
compound
avoid
target
bind
compound
human
target
exclud
top
two
hit
show
stabl
nearli
stabl
bind
energi
good
cluster
perform
dock
result
tabl
structur
shown
figur
among
final
high
affin
bind
molecul
ncoeleneterazin
n
found
interact
import
residu
figur
respect
consid
middl
low
permeabl
respect
drug
exhibit
good
oral
bioavail
mostli
neg
result
ame
test
predict
preadmet
toxic
predict
data
shown
evid
carcinogen
activ
predict
preadmet
rodent
carcinogen
predict
also
analyz
admet
properti
like
bloodbrain
barrier
penetr
skin
permeabl
mdck
cell
pgp
inhibit
case
result
posit
propos
compound
data
shown
overal
pictur
emerg
studi
identif
broadspectrum
antibiot
target
well
predict
potenti
inhibitor
dna
iii
alpha
deadli
pathogen
ecoli
use
extens
silico
tool
bacteri
replic
dnae
member
c
famili
polymeras
uniqu
term
sequenc
bacteri
replic
dna
polymeras
iii
share
sequenc
similar
strikingli
differ
canon
dna
polymeras
includ
eukaryot
replic
polymeras
report
dna
polymeras
respons
pathogen
surviv
drug
resist
consid
drug
target
broad
group
gramposit
pathogen
staphylococcu
streptococcu
enterococcu
mycoplasma
also
report
dna
polymeras
iii
inactiv
would
imped
surviv
mycobacterium
tuberculosi
within
host
sinc
bacteri
evolut
aim
acquir
resist
singl
multipl
antibiot
ensur
surviv
environ
develop
new
convent
antibiot
also
novel
compound
altern
strategi
battl
bacteri
infect
becom
topic
wide
recogn
need
studi
number
criteria
essenti
protein
dissimilar
host
conserv
among
pathogen
tabl
lowest
dock
energi
import
residu
bind
site
observ
interact
ligand
drugbank
percentag
human
intestin
absorpt
plasma
protein
bind
cell
permeabl
carcinogen
rat
drug
target
identif
subtract
genom
analysi
approach
avail
drug
databas
virtual
screen
etc
util
explor
potenti
drug
target
well
predict
drug
block
dnae
deadli
e
coli
strain
silico
strategi
use
screen
novel
altern
target
way
design
develop
new
drug
emerg
human
pathogen
